Efficacy and Safety of Tacrolimus in Combination With Ripertamab in the Initial Treatment of Patients With MCD
Clinical trial NCT06405100 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06405100
- Sponsor
- Air Force Military Medical University, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-01
- Primary completion
- 2026-04-01
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.